Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Transplantation
Volume 2017 (2017), Article ID 3197042, 6 pages
https://doi.org/10.1155/2017/3197042
Case Report

Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation

1Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France
2Department of Nephrology and Transplantation, University Hospital of Strasbourg, Strasbourg, France
3Université Paul Sabatier, Toulouse, France
4INSERM U1043, IFR-BMT, CHU Purpan, Toulouse, France

Correspondence should be addressed to Nassim Kamar; rf.esuoluot-uhc@n.ramak

Received 23 August 2017; Accepted 16 November 2017; Published 28 December 2017

Academic Editor: Ryszard Grenda

Copyright © 2017 Luca Lanfranco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Luca Lanfranco, Melanie Joly, Arnaud Del Bello, et al., “Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation,” Case Reports in Transplantation, vol. 2017, Article ID 3197042, 6 pages, 2017. doi:10.1155/2017/3197042